We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+48.85%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$634M
AUM Growth
+$33.5M
Cap. Flow
-$90.2M
Cap. Flow %
-14.22%
Top 10 Hldgs %
8.15%
Holding
413
New
130
Increased
19
Reduced
118
Closed
127

Top Buys

Rank Stock Value
1
LPSN icon
LivePerson
LPSN
+$4.19M
2
NVTR
Nuvectra Corporation Common Stock
NVTR
+$4.14M
3
TBCH
Turtle Beach Corp
TBCH
+$4.13M
4
BEAT
BioTelemetry, Inc.
BEAT
+$4.07M
5
TCMD icon
Tactile Systems Technology
TCMD
+$4.05M

Top Sells

Rank Stock Value
1
NKTR icon
Nektar Therapeutics
NKTR
+$6.81M
2
CUTR
Cutera, Inc.
CUTR
+$4.92M
3
VCEL icon
Vericel Corp
VCEL
+$4.77M
4
ESPR
Esperion Therapeutics
ESPR
+$4.75M
5
INST
Instructure, Inc.
INST
+$4.68M

Sector Composition

Rank Sector Weight
1 Healthcare 27.66%
2 Technology 24.9%
3 Consumer Discretionary 14.4%
4 Industrials 10.81%
5 Financials 5.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTA icon
251
Enanta Pharmaceuticals
ENTA
$366M
$727K 0.11%
6,275
-3,863
-38% -$385K
MHH icon
252
Mastech Digital
MHH
$93.1M
$725K 0.11%
90,108
– –
ARNA
253
DELISTED
Arena Pharmaceuticals Inc
ARNA
$720K 0.11%
16,509
-27,603
-63% -$1.19M
AMRC icon
254
Ameresco
AMRC
$1.12B
$714K 0.11%
59,528
-29,372
-33% -$350K
ALOT icon
255
AstroNova
ALOT
$225M
$708K 0.11%
+37,566
New +$688K
FATE icon
256
Fate Therapeutics
FATE
$286M
$699K 0.11%
61,681
-217,480
-78% -$2.4M
CRAI icon
257
CRA International
CRAI
$1.16B
$691K 0.11%
13,585
-7,869
-37% -$433K
GNK icon
258
Genco Shipping & Trading
GNK
$1.11B
$683K 0.11%
+44,047
New +$749K
KIN
259
DELISTED
Kindred Biosciences, Inc.
KIN
$680K 0.11%
63,883
– –
OTRK
260
DELISTED
Ontrak
OTRK
$679K 0.11%
+1,123
New +$595K
SFST icon
261
Southern First Bancshares
SFST
$591M
$675K 0.11%
15,277
– –
IEC
262
DELISTED
IEC Electronics Corp.
IEC
$673K 0.11%
+115,441
New +$597K
CGRN
263
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$671K 0.11%
+46,917
New +$700K
PFSW
264
DELISTED
PFSweb, Inc.
PFSW
$671K 0.11%
+69,015
New +$681K
ASUR icon
265
Asure Software
ASUR
$232M
$645K 0.1%
+40,409
New +$660K
BRT
266
BRT Apartments
BRT
$281M
$641K 0.1%
50,286
– –
WLFC icon
267
Willis Lease Finance
WLFC
$1.7B
$632K 0.1%
59,997
– –
TFIN icon
268
Triumph Financial Inc
TFIN
$1.81B
$631K 0.1%
15,486
-15,057
-49% -$608K
LLEX
269
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$630K 0.1%
+121,241
New +$567K
CTRN icon
270
Citi Trends
CTRN
$555M
$628K 0.1%
22,876
-12,005
-34% -$361K
ENSV
271
DELISTED
Enservco Corp.
ENSV
$604K 0.1%
+34,739
New +$582K
HBIO icon
272
Harvard Bioscience
HBIO
$27.5M
$600K 0.09%
11,207
-2,047
-15% -$105K
SYRE icon
273
Spyre Therapeutics
SYRE
$8.54B
$600K 0.09%
2,269
– –
DRNA
274
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$579K 0.09%
47,286
– –
LUNA
275
DELISTED
Luna Innovations Incorporated
LUNA
$570K 0.09%
191,168
-76,467
-29% -$246K
9 10
11
12 13

Similar funds

NEPWA
New England Private Wealth Advisors Wellesley, Massachusetts $866M AUM 15.25% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
MCM
Makena Capital Management Menlo Park, California $866M AUM 17.79% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
RB
Rodgers Brothers Harmony, Pennsylvania $866M AUM 30.05% 1-Year Est. Return
BGC
Blue Grotto Capital Atlanta, Georgia $868M AUM 56.95% 1-Year Est. Return
ICCFIA
IDG China Capital Fund III Associates Central Hong Kong, China $868M AUM 24.3% 1-Year Est. Return

EAM Investors's Q2 2018 Portfolio in Review

As of Q2 2018, EAM Investors held 413 positions worth $634M, up 5.6% from $601M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

EAM Investors withdrew a net $90.2M in Q2 2018, closing 127 positions and reducing 118 holdings. Its most notable exit was Nektar Therapeutics, an estimated $6.81M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, EAM Investors opened a new position in LivePerson worth $4.69M.

  • EAM Investors's largest Q2 2018 buy was LivePerson: 14,807 shares worth $4.69M.
  • EAM Investors added most to Malibu Boats in Q2 2018, an estimated $3.06M increase.
  • EAM Investors's biggest Q2 2018 reduction was Vericel Corp, cutting an estimated $4.77M.
  • EAM Investors fully exited Nektar Therapeutics in Q2 2018, selling an estimated $6.81M.
  • EAM Investors's ten largest holdings make up 8.1% of its $634M portfolio in Q2 2018.
  • EAM Investors opened 130 new positions and closed 127 in Q2 2018.
  • EAM Investors's portfolio value rose 5.6% quarter-over-quarter to $634M.

Based on EAM Investors's 13F filing for Q2 2018, filed 3 Aug 2018.